HbA1c values determine the outcome of intrasheath injection of triamcinolone for diabetic flexor tenosynovitis.
Kameyama
Makoto
M
Department of Orthopaedic Surgery, Saiseikai Central Hospital, 1-4-17, Mita, Minatoku, Tokyo, 108-0073, Japan. bza00713@nifty.com
Funae
Osamu
O
Meguro
Shu
S
Atsumi
Yoshihito
Y
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000378:metabolism; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D053682:Tendon Entrapment / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D016896:Treatment Outcome; D014221:Triamcinolone / Q000008:administration & dosage*
D000893:Anti-Inflammatory Agents; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D014221:Triamcinolone